Back to all MindMaze Therapeutics Holding SA press releases
MindMaze Therapeutics Holding SA
- OTCQB:MMTZF
- SIX:MMTX
MindMaze Completes Organisational Simplification and Updates Neuro.io Financing
Published
At a glance
- Company
- MindMaze Therapeutics Holding SA
- Listings
- OTCQB:MMTZF, SIX:MMTX
- Announcement type
- Financing
- Published
- Source announcement
- eqs-news.com
| Measure | Figure |
|---|---|
| Gross cash proceeds | CHF 4.0 million |
| Mandatory convertible loan notes | CHF 2,850,900 |
| Ordinary shares | 12,395,217 ordinary shares |
Figures are quoted from this announcement and selected automatically.
FAQSIR Generated from this announcement View original release below for safe harbor and regulatory notices
Announcement Summary
MindMaze Therapeutics Holding SA (SIX: MMTX) reported completion of its organizational simplification and an update on its Neuro.io equity financing.
- The simplification disposed of substantially all remaining non-neurology legacy operations; consideration included upfront cash and potential future contingent consideration.
- The CHF 8.0 million financing’s initial tranche delivered gross cash proceeds of CHF 4.0 million, with 4,970,000 treasury shares transferred to Neuro.io.
- CHF 2,850,900 of mandatory convertible loan notes converted into 12,395,217 ordinary shares under the financing terms.
- The second CHF 4.0 million tranche is expected to be funded in two installments during September and November 2026.
- The definitive financing agreement remains in effect; the company said timing or completion of the remaining investment is not assured.
The company said the transactions aimed to simplify operations, reduce the cost base, and focus on core neurology. The company is pursuing additional financing for liquidity and will provide updates on material developments.
Investor FAQs
Source announcement
- Company
- MindMaze Therapeutics Holding SA
- Title
- MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
- Published
- Source site
- eqs-news.com
Read the source announcement on eqs-news.com
FAQSIR's summary and investor FAQs are generated by AI from the text of this announcement alone, without information from other sources.
Figures, forecasts and other claims are the announcement's, not FAQSIR's. FAQSIR does not independently verify them.
Read the original press release
Full text as published, unedited.